| Factor Information | |
|---|---|
| Data ID | 477 |
| Factor | GSE(General Self-Efficacy) |
| Description | General Self-Efficacy (GSE) scale, which produces a total score ranging from 10 to 40. |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | Prognosis |
| Objective | health status and quality of life |
| Conclusion | GSE adds considerably to our understanding of patient-reported outcomes in adults with congenital heart disease. Given that self-efficacy is a modifiable psychosocial factor, it may be an important focus for interventions targeting congenital heart disease patients well-being. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 29661025 |
| Year | 2018 |
| Title | Self-efficacy as a predictor of patient-reported outcomes in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | General Self-Efficacy (GSE) scale | |
| Region | Toronto, Canada & Bern, Switzerland | |
| Method | Hierarchical multivariable linear regression analysis | |
| Race | North America & Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | 454 | N/A |
| Age | median age 32 years, range: 18–81) | N/A |
| Gender (Male: Female) | 248:206 | N/A |
| Marker Level | N/A | N/A |
